The stocks of the ‘Magnificent Seven’ technology giants will likely continue to outperform in 2025, even though a market crash is now “inevitable,” Bank
On Tuesday, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Sanofi SA’s (NASDAQ:SNY) Phase 2b RELIEVE UCCD study met its primary endpoints in
Nvidia stock sank more than 2% early Tuesday, putting the AI chipmaker down 14% from its record high closing price of $148.88 in early November.
Professional investors have become “super bullish” on stocks, according to a popular Bank of America survey. That doesn’t bode well for the market’s
Retail sales increased in November amid a strong start to the holiday shopping season.
Here’s what could be next for SoundHound AI.
EVgo said its largest investor would be selling 23 million shares of Class A common stock, sending them sharply lower Tuesday morning.
On Tuesday, Biomea Fusion Inc. (NASDAQ:BMEA) revealed topline results from the ongoing COVALENT-111 study of icovamenib in patients with type 2 diabetes
Quantum Computing was awarded a contract by NASA's Goddard Space Flight Center to use its entropy quantum optimization machine to help the space agency's
The company’s chronic thyroid eye disease treatment, veligrotug, was able to reduce eye bulge by 56% compared with placebo.
